Bart Geers graduated laude with a master's in pharmaceutical sciences in 2008, after which he obtained a PhD in pharmaceutical sciences from Ghent University in 2013. Bart began his career in the pharmaceutical industry and took various roles in research management and spin-out creation at Ghent University.
Currently, Bart works as the investment manager for KULeuven Research & Development (LRD) where he coaches start-up projects in health- and biotechnology; manages the spin-out, investment process, and operational execution of these projects, and represents the Gemma Frisius Fund. Next, he supports business development within KU Leuven R & R&D, the largest TTO in Europe. Bart holds board positions in various KU Leuven spin-offs.